Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-25/scribe-therapeutics-to-demonstrate-scientific-and-corporate-leadership-at-upcoming-conferences
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522194036/en/Scribe-Therapeutics-Reports-Positive-Preclinical-Data-on-its-Novel-CRISPR-Technologies-at-the-2025-EAS-Congress-and-ASGCT-Annual-Meeting
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505857479/en/Scribe-Therapeutics-to-Highlight-In-Vivo-CRISPR-based-Genome-Editing-Data-for-Duchenne-Muscular-Dystrophy-at-ASGCT-2025-in-Addition-to-Joint-Presentation-with-Prevail-Therapeutics-a-Part-of-Lillys-Gene-Therapy-Division
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428937434/en/Scribe-Achieves-Milestone-for-In-Vivo-Program-in-Collaboration-with-Prevail-Therapeutics-a-part-of-Lillys-Gene-Therapy-Division-and-Announces-ASGCT-Joint-Presentation-on-Self-Inactivating-AAV-Technology-for-Neurological-and-Neuromuscular-Disorders
23 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250423824348/en/Scribe-Therapeutics-to-Unveil-Latest-Preclinical-Data-on-Proprietary-CRISPR-Epigenetic-Silencing-Technology-for-LDL-C-Lowering-at-the-2025-EAS-Congress
26 Feb 2025
// BUSINESSWIRE
ABOUT THIS PAGE